- Sponsored Content
Simple In-House Mycoplasma Testing Method for Regulatory Expectations and Rapid, Confident, and Actionable Results
December 7, 2022
20 Min View
Date: Dec 7, 2022
Duration: 20 Min
Sponsored by Thermo Fisher Scientific
Mycoplasma contamination is a risk to cell-based biologics manufacturing, potentially jeopardizing patient safety and product quality. Therefore, regulatory guidance globally requires manufactures to routinely employ a validated mycoplasma detection strategy for lot-release of their drug product. Beyond meeting regulatory expectations, the implementation of an in-house mycoplasma testing method is extremely valuable, providing companies with rapid, actionable data for both lot-release and raw materials testing, saving both time and money.
The introduction of live mycoplasma or live mycoplasma cultures in production facilities is not ideal. Regulatory guidance has evolved to include rapid molecular methods that do not require live cultures or live mycoplasma, but its important to implement a testing method that meets sensitivity and specificity requirements and is validatable per industry expectations.
In this webinar, we present an overview of worldwide regulatory guidance for mycoplasma testing, as well as a mycoplasma testing method that has been accepted by regulatory authorities worldwide across various therapeutic modalities. Experience will be shared using purified genomic DNA for limit of detection validations. We will simplify other common challenges and learnings from a decade of experience, such as the selection of a representative sample in cell therapy products and techniques for sample preparation to help achieve regulatory requirements.
An in-depth look at mycoplasma testing, regulatory guidance, and expectations.
Details of a highly sensitive, specific, and robust method for rapid mycoplasma detection with a strong regulatory acceptance track-record for lot-release testing.
Limit of detection validation scheme using genomic DNA instead of live mycoplasma.
Tips and tricks learned over 10 years of field support from sample selection, preparation, and validation guidance.
Just fill out the form below to view the recorded webcast now.
Ins & Outs: Gonzalez but not forgotten at AbbVieFeb 29, 2024|2 Min Read
Miltenyi: MoU ‘paves way’ for India’s CGT ambitionsFeb 29, 2024|2 Min Read
Experic expands into Europe with Ireland facilityFeb 29, 2024|2 Min Read
Peas in a pod: BioCina and NovaCina ink fill/finish dealFeb 28, 2024|1 Min Read
Mar 11 - Mar 14, 2024
Mar 11 - Mar 14, 2024
Accelerate speed to market for your next generation mAbs, vaccines, cell therapy, and gene therapy products. At the BioProcess International US West event in San Diego, CA, in March 2024 you can access today's innovative strategies and technologies designed to improve process efficiencies and maintain product quality across all phases of bioprocessing.Agenda